Medical Capital Notes Class Action Lawsuit Filed for Investors

A class action lawsuit has been filed on behalf of investors who purchased Medical Capital Notes, alleging that several brokerage firms violated federal securities laws by selling the unregistered notes under false and misleading prospectuses.

The Medical Capital class action lawsuit was filed on behalf of all persons or entities who purchased investment notes issued by Medical Provider Financial Corp. III, Medical Provider Financial Corp. IV, Medical Provider Funding Corp V or Medical Provider Funding Corp VI, commonly referred to as Medical Capital Notes, from Capital Financial Services, National Securities Corp., Cullum & Burks, Securities America, Ameriprise Financial or CapWest Securities on or after September 18, 2006.

Medical Capital was set up to purchase accounts receivables of medical providers and package them as private investments. The firm raised $2.2 billion from 20,000 investors over a six-year period, but has been charged with defrauding investors.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

In July, the Securities Exchange Commission (SEC) filed charges against Medical Capital, indicating that it conducting a number of questionable transactions with itself, some of which appeared to include receivables that did not actually exist. The SEC also indicated that the company made investments that had nothing to do with medical receivables, such as investing $7 million into a mobile phone application consisting of live video feed of a hamster in a cage, and $20 million into a movie.

The class action lawsuit over Medical Capital Notes alleges the brokerage firms violated federal securities laws by selling notes that were not registered with the SEC. The lawsuit also alleges that Medical Capital investments were misrepresented due to false and misleading information given out about the track records, the qualifications of those managing the company and the overall risks of the investments.

A number of investors have also filed individual Medical Capital lawsuit arbitration claims against their brokers through the Financial Industry Regulatory Authority (FINRA) to recoup their losses. The claims allege that through basic due diligence, brokerage firms should have discovered the Medical Capital fraud and irregularities.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL
Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL (Posted yesterday)

Plaintiffs say a federal judge should not waste time on a phased discovery plan requiring them to first prove Suboxone strips can cause tooth decay, saying the science is obvious and such a plan could delay resolution of hundreds of product liability lawsuits.